Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm

被引：0
|
作者：
Jonathan Golledge
Clare Arnott
Joseph Moxon
Helen Monaghan
Richard Norman
Dylan Morris
Qiang Li
Greg Jones
Justin Roake
Matt Bown
Bruce Neal
机构：
[1] James Cook University,Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry
[2] The Townsville University Hospital,The Department of Vascular and Endovascular Surgery
[3] James Cook University,The Australian Institute of Tropical Health and Medicine
[4] George Institute Australia,Curtin School of Population Health, Faculty of Health Sciences
[5] University of New South Wales,Department of Surgical Sciences, Division of Health Sciences
[6] Curtin University,Department of Surgery
[7] University of Otago,Department of Cardiovascular Services
[8] University of Otago,undefined
[9] University of Leicester,undefined
来源：
Trials | / 22卷
关键词：
Abdominal aortic aneurysm; Metformin; Randomised controlled trial; Placebo;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 49 条
  • [31] Metformin intervention against ovarian toxicity during chemotherapy for early breast cancer: Study protocol for a randomized double-blind placebo-controlled trial
    Zhang, Jinjin
    Ma, Xiangyi
    Li, Ya
    Liu, Ronghua
    Li, Yan
    Zhang, Panshi
    Ren, Wu
    Cui, Pengfei
    Wang, Bo
    Zhang, Minli
    Jin, Yan
    Li, Xingrui
    Wang, Shixuan
    MATURITAS, 2020, 137 : 1 - 6
  • [32] Rivaroxaban in patients with abdominal aortic aneurysm and high-sensitivity C-reactive protein elevation (BANBOO): study protocol for a randomized, controlled trial
    Jingyuan Li
    Sicong Ma
    Xiu Jia
    Yingzhen Bu
    Tienan Zhou
    Lei Zhang
    Miaohan Qiu
    Xiaozeng Wang
    Trials, 24
  • [33] High-risk and low-risk screening for abdominal aortic aneurysm both reduce aneurysm-related mortality. A stratified analysis from a single-centre randomised screening trial
    Lindholt, J. S.
    Juul, S.
    Henneberg, E. W.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2007, 34 (01) : 53 - 58
  • [34] Efficacy and safety of linagliptin 2.5 mg twice daily versus 5 mg once daily in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, placebo-controlled trial
    Ross, Stuart A.
    Rafeiro, Elizabeth
    Meinicke, Thomas
    Toorawa, Robert
    Weber-Born, Sonja
    Woerle, Hans-Juergen
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (09) : 1465 - 1474
  • [35] Metformin for the prevention of diabetes among people with HIV and either impaired fasting glucose or impaired glucose tolerance (prediabetes) in Tanzania: a Phase II randomised placebo-controlled trial
    Garrib, Anupam
    Kivuyo, Sokoine
    Bates, Katie
    Ramaiya, Kaushik
    Wang, Duolao
    Majaliwa, Edna
    Simbauranga, Rehema
    Charles, Godbless
    van Widenfelt, Erik
    Luo, Huanyan
    Alam, Uazman J.
    Nyirenda, Moffat
    Jaffar, Shabbar
    Mfinanga, Sayoki
    META Trial Team
    DIABETOLOGIA, 2023, 66 (10) : 1882 - 1896
  • [36] Metformin for the prevention of diabetes among people with HIV and either impaired fasting glucose or impaired glucose tolerance (prediabetes) in Tanzania: a Phase II randomised placebo-controlled trial
    Anupam Garrib
    Sokoine Kivuyo
    Katie Bates
    Kaushik Ramaiya
    Duolao Wang
    Edna Majaliwa
    Rehema Simbauranga
    Godbless Charles
    Erik van Widenfelt
    Huanyan Luo
    Uazman Alam
    Moffat J. Nyirenda
    Shabbar Jaffar
    Sayoki Mfinanga
    Diabetologia, 2023, 66 : 1882 - 1896
  • [37] Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial
    Nini de Boer
    Sinan Guloksuz
    Caroline van Baal
    Leonie Willebrands
    Jeroen Deenik
    Christiaan H. Vinkers
    Inge Winter-van Rossum
    Janneke Zinkstok
    Ingeborg Wilting
    Jasper B. Zantvoord
    Frank Backx
    Wilma E. Swildens
    Marieke Schouw
    Jan Bogers
    Folkwin Hulshof
    Rudolf de Knijff
    Peter Duindam
    Mike Veereschild
    Maarten Bak
    Geert Frederix
    Lieuwe de Haan
    Jim van Os
    Wiepke Cahn
    Jurjen J. Luykx
    BMC Psychiatry, 21
  • [38] Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial
    de Boer, Nini
    Guloksuz, Sinan
    van Baal, Caroline
    Willebrands, Leonie
    Deenik, Jeroen
    Vinkers, Christiaan H.
    Winter-van Rossum, Inge
    Zinkstok, Janneke
    Wilting, Ingeborg
    Zantvoord, Jasper B.
    Backx, Frank
    Swildens, Wilma E.
    Schouw, Marieke
    Bogers, Jan
    Hulshof, Folkwin
    de Knijff, Rudolf
    Duindam, Peter
    Veereschild, Mike
    Bak, Maarten
    Frederix, Geert
    de Haan, Lieuwe
    van Os, Jim
    Cahn, Wiepke
    Luykx, Jurjen J.
    BMC PSYCHIATRY, 2021, 21 (01)
  • [39] Synbiotics in patients at risk for spontaneous preterm birth: protocol for a multi-centre, double-blind, randomised placebo-controlled trial (PRIORI)
    Nulens, Katrien
    Papy, Els
    Tartaglia, Katrien
    Dehaene, Isabelle
    Logghe, Hilde
    Van Keirsbilck, Joachim
    Chantraine, Frederic
    Masson, Veronique
    Simoens, Eva
    Gysemans, Willem
    Bruckers, Liesbeth
    Lebeer, Sarah
    Allonsius, Camille Nina
    Oerlemans, Eline
    Steensels, Deborah
    Reynders, Marijke
    Timmerman, Dirk
    Devlieger, Roland
    Van Holsbeke, Caroline
    TRIALS, 2024, 25 (01)
  • [40] DANCER: Study protocol of a prospective, non-randomized controlled trial for crossed limb versus standard limb configuration in endovascular abdominal aortic aneurysm repair
    Shen, Yinzhi
    Wang, Jiarong
    Zhao, Jichun
    Yuan, Ding
    Wang, Tiehao
    Huang, Bin
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
12345